Cases 11 - 20 of 5,522
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as 1:2023cv00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD.,
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2023cv00089
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2023cv00088
Plaintiff:
Actelion Pharmaceuticals Ltd. and Actelion Pharmaceuticals US, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PFIZER INC. et al v. SYNTHON PHARMACEUTICALS INC. et al
as 1:2023cv00936
Plaintiff:
PFIZER INC., WARNER-LAMBERT COMPANY LLC, PF PRISM C.V. and others
Defendant:
SYNTHON PHARMACEUTICALS, INC., SYNTHON B.V. and SYNTHON INTERNATIONAL HOLDING B.V.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Zaklady Farmaceutyczne Polpharma S.A. v. Kartha Pharmaceuticals, Inc.
as 23-1870
Plaintiff / Appellant:
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Defendant / Appellee:
KARTHA PHARMACEUTICALS, INC.
Lacks v. Ultragenyx Pharmaceutical, Inc
as 1:2023cv02171
Plaintiff:
Ron L. Lacks
Defendant:
Ultragenyx Pharmaceutical, Inc
Cause Of Action: 28 U.S.C. § 1332 Diversity Action
Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
as 1:2023cv00788
Plaintiff:
Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals, Inc.
Defendant:
BendaRx USA Corp
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals, Inc. v. Centers for Medicare & Medicaid Services
as 23-1457
Plaintiff / Appellant:
VANDA PHARMACEUTICALS, INC.
Defendant / Appellee:
CENTERS FOR MEDICARE & MEDICAID SERVICES and CHIQUITA BROOKS-LASURE, in her official capacity as Administrator of Centers for Medicare & Medicaid Services
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant:
Abraxis Bioscience, LLC
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff:
Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
